XML 52 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholder's Equity (Deficit) (Tables)
9 Months Ended
Sep. 30, 2020
Summary of Issued and Cancelled Shares of Common Stock During the three and nine months ended September 30, 2020 and September 30, 2019, the Company issued and cancelled the following shares of common stock:

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

Shares

 

 

Average Price per Share

 

 

Shares

 

 

Average Price per Share

 

 

Shares

 

 

Average Price per Share

 

 

Shares

 

 

Average Price per Share

 

Common stock issued

   in connection with initial public

   offering

 

11,500,000

 

 

$

15.00

 

 

 

 

 

$

 

 

 

11,500,000

 

 

$

15.00

 

 

 

 

 

$

 

Acquisitions

 

 

 

 

 

 

 

25,408

 

 

 

26.90

 

 

 

791,139

 

 

 

31.60

 

 

 

150,439

 

 

 

22.41

 

Redemption of series A-1 preferred stock

 

1,786,739

 

 

 

15.00

 

 

 

 

 

 

 

 

 

1,786,739

 

 

 

15.00

 

 

 

 

 

 

 

Exercise of warrant options

 

2,534,239

 

 

 

0.01

 

 

 

 

 

 

 

 

 

2,534,239

 

 

 

0.01

 

 

 

 

 

 

 

Exercise of options

 

16,850

 

 

 

8.92

 

 

 

7,150

 

 

 

6.03

 

 

 

20,350

 

 

 

9.27

 

 

 

22,675

 

 

 

18.01

 

Restricted shares, net

 

8,333

 

 

 

24.00

 

 

 

 

 

 

 

 

 

8,333

 

 

 

24.00

 

 

 

 

 

 

 

Cancellation of shares

 

(117,785

)

 

 

17.15

 

 

 

 

 

 

 

 

 

(117,785

)

 

 

17.15

 

 

 

 

 

 

 

 

 

15,728,376

 

 

$

12.82

 

 

 

32,558

 

 

$

22.32

 

 

 

16,523,015

 

 

$

13.72

 

 

 

173,114

 

 

$

21.83

 

 

Schedule of Share Authorized to be Issue and Available for Grant The following number of shares were authorized to be issued and available for grant as of September 30, 2020 and September 30, 2019:

 

 

 

September 30, 2020

 

 

 

2017 Plan

 

 

2013 Plan

 

Shares authorized to be issued

 

 

2,945,443

 

 

 

2,047,269

 

Shares available for grant

 

 

1,233,266

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

September 30, 2019

 

 

 

2017 Plan

 

 

2013 Plan

 

Shares authorized to be issued

 

 

981,800

 

 

 

2,074,604

 

Shares available for grant

 

 

159,428

 

 

 

 

 

Schedule of Stock Compensation Expense

Total stock compensation expense for the Plans was as follows:

 

 

 

Three Months Ended September 30,

 

 

 

2020

 

 

2019

 

 

 

2017 plan

 

 

2013 plan

 

 

 

 

 

 

2017 plan

 

 

2013 plan

 

 

 

 

 

 

 

Options

 

 

Restricted Stock

 

 

Options

 

 

Total

 

 

Options

 

 

Restricted Stock

 

 

Options

 

 

Total

 

Cost of revenue

 

$

276

 

 

$

 

 

$

(5

)

 

$

271

 

 

$

278

 

 

$

 

 

$

97

 

 

$

375

 

Selling, general and administrative expense

 

 

592

 

 

 

233

 

 

 

53

 

 

 

878

 

 

 

185

 

 

 

111

 

 

 

384

 

 

 

680

 

 

 

$

868

 

 

$

233

 

 

$

48

 

 

$

1,149

 

 

$

463

 

 

$

111

 

 

$

481

 

 

$

1,055

 

 

 

 

Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

 

 

2017 plan

 

 

2013 plan

 

 

 

 

 

 

2017 plan

 

 

2013 plan

 

 

 

 

 

 

 

Options

 

 

Restricted Stock

 

 

Options

 

 

Total

 

 

Options

 

 

Restricted Stock

 

 

Options

 

 

Total

 

Cost of revenue

 

$

973

 

 

$

 

 

$

126

 

 

$

1,099

 

 

$

623

 

 

$

 

 

$

390

 

 

$

1,013

 

Selling, general and administrative expense

 

 

1,178

 

 

 

973

 

 

 

189

 

 

 

2,340

 

 

 

457

 

 

 

323

 

 

 

1,784

 

 

 

2,564

 

 

 

$

2,151

 

 

$

973

 

 

$

315

 

 

$

3,439

 

 

$

1,080

 

 

$

323

 

 

$

2,174

 

 

$

3,577

 

 

Summary of Weighted Average Assumptions Used in Black-Sholes Option-pricing Model

The following weighted-average assumptions were used in the Black-Sholes option-pricing model calculation for the nine months ended September 30, 2020 and September 30, 2019:

 

 

 

September 30,

 

 

September 30,

 

 

 

2020

 

 

2019

 

Common stock value (per share)

 

$

16.36

 

 

$

27.30

 

Expected volatility

 

 

46.14

 

 

 

47.94

 

Risk-free interest rate

 

 

0.41

 

 

 

2.15

 

Expected life (years)

 

 

7

 

 

 

7

 

Forfeiture rate

 

None

 

 

None

 

Dividend rate

 

None

 

 

None

 

Schedule of Common Stock Reserved for Future Issuance

Common Stock Reserved for Future Issuances—At September 30, 2020 and September 30, 2019, the Company has reserved certain stock of its authorized but unissued common stock for possible future issuance in connection with the following:

 

 

 

September 30,

 

 

December 31,

 

 

 

2020

 

 

2019

 

Warrants

 

 

116,350

 

 

 

650,590

 

Montrose 2013 Stock Incentive Plan

 

 

2,047,269

 

 

 

2,058,619

 

Montrose 2017 Stock Incentive Plan

 

 

2,945,443

 

 

 

997,785

 

Common stock reserved for future issuance

 

 

5,109,062

 

 

 

3,706,994

 

Montrose Amended & Restated 2017 Stock Incentive Plan  
Summary of Stock Option Activity The following summarizes the options activity of the 2017 Plan for the nine months ended September 30, 2020 and September 30, 2019:

 

 

 

Options to

Purchase

Common

Stock

 

 

Weighted-

Average

Exercise

Price per

Share

 

 

Weighted

Average

Grant Date

Fair Value

per Share

 

 

Weighted

Average

Remaining

Contract Life

(in Years)

 

 

Aggregate

Intrinsic

Value

of In-The-

Money

Options (in

Thousands)

 

Outstanding at December 31, 2018

 

 

257,762

 

 

$

20

 

 

$

10

 

 

 

-

 

 

$

1,151

 

Granted

 

 

356,470

 

 

 

27

 

 

 

14

 

 

 

-

 

 

 

 

Forfeited/ cancelled

 

 

(17,700

)

 

 

19

 

 

 

 

 

 

-

 

 

 

 

Outstanding at September 30, 2019

 

 

596,532

 

 

 

24

 

 

 

12

 

 

 

8.07

 

 

 

4,693

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2019

 

 

617,852

 

 

 

24

 

 

 

12

 

 

 

7.82

 

 

 

4,693

 

Granted

 

 

851,877

 

 

 

32

 

 

 

12

 

 

 

-

 

 

 

 

Forfeited/ cancelled

 

 

(14,375

)

 

 

22

 

 

 

 

 

 

-

 

 

 

 

Exercised

 

 

(925

)

 

 

14

 

 

 

 

 

 

-

 

 

 

7,918

 

Outstanding at September 30, 2020

 

 

1,454,429

 

 

 

21

 

 

 

12

 

 

 

7.59

 

 

 

7,649

 

Exercised at September 30, 2020

 

 

925

 

 

 

14

 

 

 

 

 

 

7.33

 

 

 

7,649

 

Options vested and expected to vest

 

 

1,454,429

 

 

 

21

 

 

 

 

 

 

 

9.04

 

 

 

7,649

 

 

Montrose Amended and Restated 2013 Stock Option Plan  
Summary of Stock Option Activity

Montrose Amended & Restated 2013 Stock Option Plan—The following summarizes the activity of the 2013 Plan for the nine months ended September 30, 2020 and September 30, 2019:

 

 

 

Options to

Purchase

Common

Stock

 

 

Weighted-

Average

Exercise

Price per

Share

 

 

Weighted

Average

Grant Date

Fair Value

per Share

 

 

Weighted

Average

Remaining

Contract Life

(in Years)

 

 

Aggregate

Intrinsic

Value

of In-The-

Money

Options (in

Thousands)

 

Outstanding at December 31, 2018

 

 

1,900,404

 

 

$

6

 

 

$

1

 

 

 

7.30

 

 

 

33,290

 

Forfeited/ cancelled

 

 

(14,500

)

 

 

8

 

 

 

 

 

 

-

 

 

 

 

Expired

 

 

(5,400

)

 

 

8

 

 

 

 

 

 

-

 

 

 

 

Exercised

 

 

(19,010

)

 

 

6

 

 

 

 

 

 

-

 

 

 

466

 

Outstanding at September 30, 2019

 

 

1,861,494

 

 

 

6

 

 

 

1

 

 

 

6.65

 

 

 

47,381

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2019

 

 

1,855,469

 

 

 

6

 

 

 

1

 

 

 

6.40

 

 

 

46,617

 

Forfeited/ cancelled

 

 

(7,500

)

 

 

10

 

 

 

 

 

 

-

 

 

 

 

Expired

 

 

(11,300

)

 

 

6

 

 

 

 

 

 

-

 

 

 

 

Exercised

 

 

(19,175

)

 

 

8

 

 

 

 

 

 

-

 

 

 

354

 

Outstanding at September 30, 2020

 

 

1,817,494

 

 

 

6

 

 

 

1

 

 

 

5.63

 

 

 

33,772

 

Exercised at September 30, 2020

 

 

221,025

 

 

 

6

 

 

 

 

 

 

5.14

 

 

 

33,772

 

Options vested and expected to vest

 

 

1,817,494

 

 

 

6

 

 

 

 

 

 

5.17

 

 

 

33,772